Involvement of PKC βII in anti-proliferating action of a new antitumor compound gnidimacrin

International Journal of Cancer

Volumn 105, Issue 5, 2003, Pages 601-606

  Yoshida, Mitsuzi ^a   Heike, Yuji ^b   Ohno, Shigeo ^c   Ikekawa, Tetsuro ^d   Wakasugi, Hiro ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION SHIKOKU CANCER CENTER   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

^d Japanese Assoc for Integrative Med   (Japan)

Author keywords

Bryostatin 1; Downregulation; Gene transfection; Gnidimacrin; PKC

Indexed keywords

ANTINEOPLASTIC AGENT; BRYOSTATIN 1; CYCLIN DEPENDENT KINASE 2; DITERPENE; GNIDIMACRIN; PLANT EXTRACT; POLYCLONAL ANTIBODY; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; UNCLASSIFIED DRUG; CDK2 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE; HYBRID PROTEIN; ISOENZYME; LACTONE; MACROLIDE; PRKCA PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; TUMOR PROTEIN;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CYCLE; CELL STRAIN HL 60; CELL STRAIN K 562; CHINESE MEDICINE; CONCENTRATION RESPONSE; DOWN REGULATION; DRUG ISOLATION; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MEDICINAL PLANT; NONHUMAN; PHYTOCHEMISTRY; PLANT ROOT; PLASMID; PRIORITY JOURNAL; STELLERA CHAMAEJASME; TUMOR CELL LINE; BIOSYNTHESIS; CELL CULTURE; CELL CYCLE G1 PHASE; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG RESISTANCE; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; PATHOLOGY; PHYSIOLOGY; SMALL CELL CARCINOMA;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, SMALL CELL; CDC2-CDC28 KINASES; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASES; DITERPENES; DRUG RESISTANCE, NEOPLASM; ENZYME ACTIVATION; ENZYME INDUCTION; G1 PHASE; GENE EXPRESSION REGULATION, LEUKEMIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HL-60 CELLS; HUMANS; ISOENZYMES; K562 CELLS; LACTONES; LUNG NEOPLASMS; MACROLIDES; NEOPLASM PROTEINS; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; PROTEIN-SERINE-THREONINE KINASES; RECOMBINANT FUSION PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0038174788     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11157     Document Type: Article

References (25)

1. Yoshida M, Feng W, Saijo N, Ikekawa T. Antitumor activity of daphnane-type diterpene gnidimacrin isolated from Stellera chamaejasme L Int J Cancer 1996;66:268-73.
2. Yoshida M, Yokokura H, Hidaka H, Ikekawa T, Saijo N. Mechanism of antitumor action of PKC activator, gnidimacrin. Int J Cancer 1998;77:243-50.
3. Yoshida M, Gallick GE, Irimura T, Nicolson GL. Modification of cell surface glycoprotein, macrophage cytostasis, and blood-borne metastatic properties of the murine RAW117 large cell lymphoma by virus superinfection. Cancer Res 1987;47:2558-62.
4. Ohno S, Kawasaki H, Imajoh S, Suzuki K, Inagaki M, Yokokura H, Sakoh T, Hidaka H. Tissue-specific expression of three distinct types of rabbit protein kinase C. Nature 1987;325:161-6.
5. Ohno S, Kawasaki H, Konno Y, Inagaki M, Hidaka H, Suzuki K. A fourth type of rabbit protein kinase C. Biochemistry 1988;27:2083-7.
6. Ohno S, Mizuno K, Adachi Y, Hata A, Akita Y, Akimoto K, Osada S, Hirai S, Suzuki K. Activation of novel protein kinases Cδ and Cε upon mitogenic stimulation of quiescent rat 3Y1 fibroblasts. J Biol Chem 1994;269:17495-501.
7. Hata A, Akita Y, Suzuki K, Ohno S. Functional divergence of protein kinase C (PKC) family members. J Biol Chem 1993;268:9122-9.
8. Courage C, Budworth J, Gescher A. Comparison of ability of protein kinase C inhibitors to arrest cell growth and to alter cellular protein kinase C localisation. Br J Cancer 1995;71:697-704.
9. Shoji M, Girard PR, Mazzei GJ, Vogler WR, Kuo JF. Immunocyto-chemical evidence for phorbol ester-induced protein kinase C translocation in HL60 cells. Biochem Biophys Res Comm 1986;135: 1144-9.
10. Nishizuka Y. The role of protein kinase C in cell surface signal transduction and tumor promotion. Nature (Lond) 1984;308:693-8.
11. Kikkawa U, Kishimoto A, Nishizuka Y. The protein kinase C family: heterogeneity and its implication. Annu Rev Biochem 1989;58:31-44.
12. Wenzel-Seifert K, Schachtele C, Hummel R, Grunbaum L, Seifert R. Evidence that inhibition of phorbol ester-induced superoxide anion formation by cyclosporin A in phagocytes is not mediated by direct inhibiton of protein kinase C Biochem Pharmacol 1994;48:859-64.
13. Stanwell C, Gescher A, Bradshaw TD, Pettit GR. The role of protein kinase C isoenzymes in the growth inhibition caused by Bryostatin 1 in human A549 lung and MCF-7 breast carcinoma cells. Int J Cancer 1994;56:585-92.
14. Zang Q, Frankel P, Foster DA. Selective activation of protein kinase C isoforms by v-Src. Cell Growth Differ 1995;6:1367-73.
15. Hocevar BA, Fields AP. Selective translocation of βII-protein kinase C to the nucleus of human promyelocytic (HL60) leukemia cells. J Biol Chem 1991;266:28-33.
16. Hocevar BA, Morrow DM, Tykocinski ML, Fields AP. Protein kinase C isotypes in human erythroleukemia cell proliferation and differentiation. J Cell Sci 1992;101:671-9.
17. Murray NR, Baumgardner GP, Burns DJ, Fields AP. Protein kinase C isotypes in human erythroleukemia (K562) cell proliferation and differentiation. J Biol Chem 1993;268:15847-53.
18. Yoshida M, Feng W, Nishio K, Takahashi M, Heike Y, Saijo N, Wakasugi H, Ikekawa T. Antitumor action of the PKC activator gnidimacrin through cdk2 inhibition. Int J Cancer 2001;94:348-52.
19. Basu A. The potential of protein kinase C as a target for anticancer treatment. Pharmacol Ther 1993;59:257-80.
20. Piontek M, Hengels K-J, Porschen R, Strohmeyer G. Protein kinase C and adenylate cyclase as target for growth inhibition of human gastric cancer cells. J Cancer Res Clin Oncol 1993;119:697-9.
21. Lilly M, Brown C, Pettit G, Kraft A. Bryostatin 1: a potential anti-leukemic agent for chronic myelomonocytic leukemia. Leukemia 1991;5:283-7.
22. Szallasi Z, Krsmanovic L, Blumberg PM. Nonpromoting 12-deoxyphorbol 13-esters inhibit phorbol 12-myristate 13-acetate-induced tumor promotion in CD-1 mouse skin. Cancer Res 1993;53:2507-12.
23. Fellhauer M, Hecker E. Antineoplastic diterpene esters from Thymelaeaceae species: therapeutic indices referring to irritancy. Planta Med 1988;54:563.
24. Han ZT, Zhu XX, Yang RY, Sun JZ, Tian GF, Liu XJ, Cao GS, Newmark HL, Conney AH, Chang RL. Effect of intravenous infusions of 12-O-tetradecanoylphorbol-13-acetate (TPA) in patients with myelocytic leukemia: Preliminary studies on therapeutic efficacy and toxicity. Proc Natl Acad Sci U S A 1998;95:5357-61.
25. Han ZT, Tong YK, He LM, Zhang Y, Sun JZ, Wang TY, Zhang H, Cui YL, Newmark HL, Conney AH, Chang RL. 12-O-Tetradecanoylphorbol-13-acetate (TPA)-induced increase in depressed white blood cell counts in patients treated with cytotoxic cancer chemotherapeutic drugs. Proc Natl Acad Sci U S A 1998;95:5362-5.